Fulcrum Therapeutics Ownership | Who Owns Fulcrum Therapeutics?

Overview Forecast RevenueFinancials Chart Transcripts

Fulcrum Therapeutics Ownership Summary

Fulcrum Therapeutics is owned by 87.76% institutional investors, 1.62% insiders, and 10.62% retail investors. Ra capital management is the largest institutional shareholder, holding 18.73% of FULC shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.97% of its assets in Fulcrum Therapeutics shares.

FULC Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Fulcrum Therapeutics	87.76%	1.62%	10.62%
Sector	Healthcare Stocks	49.73%	8.84%	41.43%
Industry	Biotech Stocks	47.04%	8.74%	44.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Ra capital management	11.61M	18.73%	$71.98M
Fmr	5.33M	8.60%	$33.05M
Blackrock	4.80M	7.74%	$29.75M
Vanguard group	3.07M	4.95%	$19.04M
Suvretta capital management	2.54M	4.10%	$15.75M
Trv gp iv	2.34M	3.78%	$14.53M
Logos global management lp	1.50M	2.42%	$9.30M
Dimensional fund advisors lp	1.48M	2.39%	$9.18M
Geode capital management	1.31M	2.11%	$8.11M
Morgan stanley	1.23M	1.99%	$7.66M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Trv gp iv	2.34M	7.18%	$14.53M
Mass general brigham	205.36K	6.20%	$1.27M
Ra capital management	11.61M	0.95%	$71.98M
Logos global management lp	1.50M	0.75%	$9.30M
Suvretta capital management	2.54M	0.58%	$15.75M
Simplify asset management	674.83K	0.28%	$4.18M
Corton capital	26.17K	0.09%	$162.27K
Gsa capital partners llp	135.22K	0.06%	$838.00K
Sphera funds management	59.00K	0.05%	$365.80K
Rbf capital	125.00K	0.04%	$775.00K

Top Buyers

Holder	Shares	% Assets	Change
Blackrock	4.80M	0.00%	3.26M
State street	1.04M	0.00%	784.41K
Geode capital management	1.31M	0.00%	743.92K
Vanguard group	3.07M	0.00%	532.48K
Woodline partners lp	501.30K	0.03%	501.30K

Top Sellers

Holder	Shares	% Assets	Change
Rtw investments, lp	-	-	-5.85M
Cowen and company	-	-	-2.96M
Bioimpact capital	-	-	-1.44M
Jefferies financial group	-	-	-1.43M
Vestal point capital, lp	-	-	-1.16M

New Positions

Holder	Shares	% Assets	Change	Value
Woodline partners lp	501.30K	0.03%	501.30K	$3.11M
Assenagon asset management	497.46K	0.01%	497.46K	$3.08M
Nuveen asset management	169.55K	0.00%	169.55K	$1.05M
Sphera funds management	59.00K	0.05%	59.00K	$365.80K
Corebridge financial	33.38K	0.00%	33.38K	$207.31K

Sold Out

Holder	Change
Gamma investing	-45.00
Daiwa securities group	-138.00
Quadrant capital group	-1.04K
Bfsg	-2.51K
Belvedere trading	-3.99K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	149	9.56%	54,770,426	-15.49%	87	0.80%	77	-2.53%	35	29.63%
Jun 30, 2024	136	0.74%	64,812,412	7.35%	104	1.08%	79	9.72%	27	-3.57%
Mar 31, 2024	135	31.07%	60,375,967	-0.73%	98	1.02%	72	41.18%	28	27.27%
Dec 31, 2023	103	21.18%	60,818,520	7.84%	98	1.18%	51	45.71%	22	-12.00%
Sep 30, 2023	85	-6.59%	56,394,592	1.60%	91	1.06%	35	-10.26%	25	-21.88%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	1.85M	2.97%	-
iShares Russell 2000 ETF	1.63M	2.61%	-3.65K
Fidelity Growth Compy Commingled Pl O	1.35M	2.16%	-464.60K
Fidelity Select Biotechnology	1.14M	1.83%	-111.80K
Fidelity Growth Compy Commingled Pl S	1.05M	1.68%	-301.65K
Vanguard Institutional Extnd Mkt Idx Tr	782.47K	1.45%	-
Fidelity Select Pharmaceuticals Port	683.60K	1.10%	-
Fidelity Small Cap Index	636.81K	1.02%	-14.77K
Candriam Eqs L Biotech C USD Cap	474.70K	0.76%	474.70K
Simplify Propel Opportunities ETF	465.00K	0.75%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
May 07, 2024	Tourangeau Greg	Principal Accounting Officer	Sell	$1.83K
Mar 08, 2024	Tourangeau Greg	Vice President, Finance	Sell	$57.22K
Mar 04, 2024	Sapir Alex	See Remarks	Buy	$492.03K
May 10, 2023	Tourangeau Greg	Principal Accounting Officer	Sell	$695.10
Jan 20, 2023	RA CAPITAL MANAGEMENT, L.P.	-	Buy	$25.00M

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	-
2024 Q3	-	-
2024 Q2	-	1
2024 Q1	1	1
2023 Q3	-	-

FULC Ownership FAQ

Who Owns Fulcrum Therapeutics?

Fulcrum Therapeutics shareholders are primarily institutional investors at 87.76%, followed by 1.62% insiders and 10.62% retail investors. The average institutional ownership in Fulcrum Therapeutics's industry, Biotech Stocks , is 47.04%, which Fulcrum Therapeutics exceeds.

Who owns the most shares of Fulcrum Therapeutics?

Fulcrum Therapeutics’s largest shareholders are Ra capital management (11.61M shares, 18.73%), Fmr (5.33M shares, 8.60%), and Blackrock (4.8M shares, 7.74%). Together, they hold 35.07% of Fulcrum Therapeutics’s total shares outstanding.

Does Blackrock own Fulcrum Therapeutics?

Yes, BlackRock owns 7.74% of Fulcrum Therapeutics, totaling 4.8M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 29.75M$. In the last quarter, BlackRock increased its holdings by 3.26M shares, a 211.35% change.

Who is Fulcrum Therapeutics’s biggest shareholder by percentage of total assets invested?

Trv gp iv is Fulcrum Therapeutics’s biggest shareholder by percentage of total assets invested, with 7.18% of its assets in 2.34M Fulcrum Therapeutics shares, valued at 14.53M$.

Who is the top mutual fund holder of Fulcrum Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Fulcrum Therapeutics shares, with 2.97% of its total shares outstanding invested in 1.85M Fulcrum Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools